Johnson & Johnson (JNJ)
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Johnson & Johnson: A 6.9 Rating and What It Means for Investors
Explore the exciting world of Johnson & Johnson (JNJ -0.31%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)
Johnson & Johnson (NYSE:JNJ ) 2025 Wells Fargo Healthcare Conference September 3, 2025 11:50 AM EDT Company Participants Tim Schmid - Executive VP & Worldwide Chairman of MedTech Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Okay. Are we ready to go.
J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
JNJ halts Imaavy's rheumatoid arthritis program after trial results showed no added benefit over existing therapy.
J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?
Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.
JNJ Stock Surge Signals Confidence in New Growth Path
Johnson & Johnson's NYSE: JNJ stock chart is sending a clear signal that contrasts sharply with the persistent hum of repetitive negative headlines. While news cycles continue to circle long-running legal battles, the company's market performance paints a picture of investor confidence, with its stock climbing over 23% year-to-date.
2 Dividend Stocks Worth Doubling Down on Right Now
Dividend stocks aren't all created equal. Some decrease their payouts, or suspend them altogether, when they face headwinds.
Johnson & Johnson to invest $2B in North Carolina plant as Trump's 250% drug tariffs loom
It's a move to boost its domestic production as President Donald Trump threatens to slap devastating tariffs on pharmaceutical imports.
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Johnson & Johnson announces $2 billion investment to boost U.S. manufacturing as tariffs loom
Johnson & Johnson said on Thursday it would invest $2 billion in North Carolina as it aims to expand its U.S. manufacturing presence amid looming drug import duties proposed by President Donald Trump's administration.
Can J&J Navigate Stelara, Talc Suits, Tariff & Other Headwinds?
J&J battles Stelara losses, talc lawsuits, tariffs and China headwinds while banking on growth plans and new launches to stay resilient.
2 unstoppable dividend stocks to buy now
For long-term investors, dividend-paying companies remain a key factor as they provide both income and stability.
